Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BonsaiLab is a Spain-based life science tools company focused on distributing and supporting advanced genomics, cell biology, and molecular biology solutions for research laboratories. Rather than developing therapeutics, the company serves as a commercial and technical partner for laboratory customers in Spain and Portugal, offering instruments, consumables, analytical solutions, and scientific support. Its portfolio is centered on next-generation sequencing, single-cell analysis, spatial biology, microscopy, sample preparation, and related workflows. BonsaiLab became part of AddLife on July 4, 2024 and now operates within AddLife’s Labtech organization. The company appears to be positioned as an Iberian distributor and support organization for leading life science technology suppliers such as 10x Genomics, ZEISS, and Eurofins Genomics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BonsaiLab.